Alkermes (ALKS) Cost of Revenue (2010 - 2026)

Alkermes (ALKS) has 17 years of Cost of Revenue data on file, last reported at $61.6 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 25.17% year-over-year to $61.6 million in Q1 2026; TTM through Mar 2026 was $208.8 million, a 11.47% decrease from a year earlier, with the FY2025 full-year figure at $196.5 million, down 19.92% from the prior year.
• Cost of Revenue for Q1 2026 stood at $61.6 million, up from $46.2 million in the prior quarter.
• Over the last five years, Cost of Revenue for ALKS reached as high as $70.1 million in Q4 2023 and fell as low as $46.2 million in Q4 2025.
• Historically, Cost of Revenue has averaged $57.3 million across 5 years, with a median of $58.4 million in 2022.
• Across the five-year window, Cost of Revenue jumped 34.47% in 2022 and declined 25.61% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $53.9 million in 2022, then jumped by 30.05% to $70.1 million in 2023, then declined by 11.42% to $62.1 million in 2024, then retreated by 25.61% to $46.2 million in 2025, then surged by 33.26% to $61.6 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $61.6 million in Q1 2026, $46.2 million in Q4 2025, and $51.6 million in Q3 2025.